- Home
- CHT vs TEVA Comparison
CHT vs TEVA Comparison
Compare CHT & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHT
- TEVA
- Stock Information
- Founded
- CHT 1996
- TEVA 1901
- Country
- CHT Taiwan
- TEVA Israel
- Employees
- CHT N/A
- TEVA N/A
- Industry
- CHT Telecommunications Equipment
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CHT Telecommunications
- TEVA Health Care
- Exchange
- CHT Nasdaq
- TEVA Nasdaq
- Market Cap
- CHT 29.3B
- TEVA 23.7B
- IPO Year
- CHT 2003
- TEVA N/A
- Fundamental
- Price
- CHT $38.94
- TEVA $21.69
- Analyst Decision
- CHT
- TEVA Buy
- Analyst Count
- CHT 0
- TEVA 7
- Target Price
- CHT N/A
- TEVA $23.00
- AVG Volume (30 Days)
- CHT 93.1K
- TEVA 8.5M
- Earning Date
- CHT 01-23-2025
- TEVA 01-29-2025
- Dividend Yield
- CHT 3.77%
- TEVA N/A
- EPS Growth
- CHT 0.86
- TEVA N/A
- EPS
- CHT 0.15
- TEVA N/A
- Revenue
- CHT $7,017,266,547.00
- TEVA $16,772,000,000.00
- Revenue This Year
- CHT $3.83
- TEVA $5.74
- Revenue Next Year
- CHT $2.03
- TEVA $4.46
- P/E Ratio
- CHT $25.99
- TEVA N/A
- Revenue Growth
- CHT 3.06
- TEVA 9.81
- 52 Week Low
- CHT $35.92
- TEVA $11.48
- 52 Week High
- CHT $40.62
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- CHT 67.93
- TEVA 57.92
- Support Level
- CHT $37.44
- TEVA $21.36
- Resistance Level
- CHT $38.18
- TEVA $22.19
- Average True Range (ATR)
- CHT 0.47
- TEVA 0.59
- MACD
- CHT 0.19
- TEVA -0.11
- Stochastic Oscillator
- CHT 91.73
- TEVA 75.25
About CHT Chunghwa Telecom Co. Ltd.
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company segment consists of Consumer Business, Enterprise Business, International Business, and Others. The company generates the majority of its revenue from the Consumer Business segment. The consumer Business segment generates revenue from Mobile services, Fixed-line services, Sales, and others.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.